Table 4 |
||||
|
Inter-Group Analysis Comparing the Paired Treatment to PlaceboGroups. |
||||
|
Group OP vs. Group 0T |
Group NP vs. Group NT |
|||
|
|
||||
|
4 weeks |
8 weeks |
4 weeks |
8 weeks |
|
|
|
||||
|
LAI |
<0.0001 |
<0.0001 |
<0.0001 |
<0.0001 |
|
|
||||
|
CRP |
<0.05 |
<0.001 |
NS |
NS |
|
|
||||
|
ESR |
NS |
NS |
<0.05 |
NS |
|
|
||||
|
Weight |
<0.01 |
<0.001 |
<0.05 |
<0.01 |
|
|
||||
|
BMI |
NS |
NS |
NS |
NS |
|
|
||||
|
Based on analysis of variance F-statistics, P-values are for comparisons between overweight placebo (OP) and overweight treatment (OT) groups and between normal weight placebo (NP) and normal weight treatment (NT) groups at 4 and 8 weeks. NS = not significant. |
||||
|
Oben et al. Nutrition Journal 2009 8:38 doi:10.1186/1475-2891-8-38 |
||||
